1 Dirt-Cheap Marijuana Stock: Is it a Buy?

Namaste Technologies Inc (TSXV:N) combines two fast-growing industries into one, but is the company a buy?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Few industries present a growth potential as significant as that of the marijuana sector, but if there is one that does, it is the e-commerce industry. However, what happens when a company tries to combine both of these markets into one? That is precisely what Namaste Technologies (TSXV:N) — a Toronto-based tech company — is trying to do. While the prospect seems enticing, I believe Namaste is too risky a bet to make at the moment; here is why.

A brilliant strategy?

Since 2005, Namaste has focused on bridging the gap between cannabis-related products and technology. In many ways, the company’s mission statement is brilliant, considering how much we rely on various technological innovations in today’s world, be it to order food or to order a cab. Namaste’s cannabis-focused e-commerce websites (which span over 20 countries) and smartphone apps attract hundreds of thousands of monthly visits and serve well over a million customers.

But Namaste does more than just sell cannabis-related products. The firm’s app — NamasteMD — matches customers with healthcare providers, recommends products based on needs, etc. In short, Namaste is planning to become the one-stop shop for various products and services, creating a self-contained network, which can serve every customer’s needs. Further, the company has secured various supply agreements, although these pale in comparison with the giants of the marijuana sector.

Reasons to worry

Namaste’s business model seems like a great idea. The cannabis sector will continue to grow worldwide, and the convenience provided by technology is a great way of making cannabis-related products more accessible to consumers, many of whom likely wouldn’t have considered them otherwise. However, there are a few areas of concern.

First, Namaste is spending a considerable amount of money to develop the technology necessary to sustain its business model. This is having a negative impact on its earnings, which are currently negative. While many pot companies are in the same boat, it is still worth mentioning. Second, the largest pot companies can likely replicate many of Namaste’s platforms, at least to some extent.

The best-known e-commerce platforms became successful because they managed to build a strong competitive advantage, be it a strong network of loyal customers, unique service offerings, high switching costs, brand-name recognition, etc. Namaste hardly possesses any of these characteristics yet, and many in the pot industry have far larger distribution channels, which they can leverage to their advantage to attract increasingly more customers.

Finally, Namaste has had to deal with some drama over the past few months. Back in October of last year, the famous (or infamous) investment newsletter Citron Research came out with some scathing allegations about the company or, more precisely, about its then CEO Sean Dollinger. According to Citron Research, Dollinger had failed to disclose the details of a deal (or that a deal was made at all) between himself and another Namaste executive, David Hughes.

A special committee appointed to investigate the allegations found that they were true: Dollinger had sold his company — Dollinger Enterprises U.S. — to David Hughes without disclosing the details of the insider transaction. The board fired Dellinger and replaced him with former chief product officer Meni Morim. While the drama seems to have been dealt with, failures in stewardship are never a good look for a publicly traded company.

Should you buy?

Namaste had a stellar month in May. Unlike many of its peers, the firm’s share price actually increased by a notable margin (about 16%). Despite this performance, the company’s stock is still priced at under a dollar, which is a far cry from its all-time high of about $3.50 (reached late last year). Some might argue that at this price, there is hardly any downside in investing in Namaste. But until the pot/tech company shows it can build a sustainable moat, I think investors had better keep their distances.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned.  

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »